 Barclays PLC lowered its stake in shares of China Biologic Products Holdings Inc NASDAQ:CBPO by 7.8 during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission SEC. The institutional investor owned 8,130 shares of the biopharmaceutical companys stock after selling 691 shares during the quarter. Barclays PLCs ... 